Cap Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Cap Wealth Advisors, LLC

$892 Million
Q1 2024

A detailed history of Cap Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cap Wealth Advisors, LLC holds 268,038 shares of GILD stock, worth $18.2 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares

268,038

Previous 263,091 1.88%

Holding current value

$18.2 Million

Previous $21.3 Million 7.88%

% of portfolio

2.2%

Previous 2.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $354,106 - $431,823	4,947 Added 1.88%	268,038 $19.6 Million
Q4 2023 Jan 31, 2024	SELL	$73.27 - $83.09 $540,292 - $612,705	-7,374 Reduced 2.73%	263,091 $21.3 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $396,540 - $432,633	-5,363 Reduced 1.94%	270,465 $20.3 Million
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $292,790 - $333,968	-3,852 Reduced 1.38%	275,828 $21.3 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $328,954 - $374,780	-4,255 Reduced 1.5%	279,680 $23.2 Million

Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $52,411 - $75,244	-841 Reduced 0.3%	283,935 $24.4 Million
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $225,299 - $257,349	3,784 Added 1.35%	284,776 $17.6 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $536,449 - $604,202	9,294 Added 3.42%	280,992 $17.4 Million
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $23,168 - $29,032	-400 Reduced 0.15%	271,698 $16.2 Million
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $199,939 - $250,546	-3,452 Reduced 1.25%	272,098 $16.2 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $180,755 - $205,161	2,786 Added 1.02%	275,550 $20 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $41,900 - $45,205	619 Added 0.23%	272,764 $19.1 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $2.47 Million - $2.7 Million	38,969 Added 16.71%	272,145 $18.7 Million
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $1.27 Million - $1.45 Million	21,161 Added 9.98%	233,176 $15.1 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $3.45 Million - $3.93 Million	60,938 Added 40.34%	212,015 $12.4 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $138,669 - $174,352	2,233 Added 1.5%	151,077 $9.55 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $839,722 - $975,072	11,608 Added 8.46%	148,844 $11.5 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $7.88 Million - $10.1 Million	125,877 Added 1108.17%	137,236 $10.3 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $711,414 - $911,218	11,359 New	11,359 $849,000
Q3 2019 Oct 29, 2019	SELL	$62.51 - $69.0 $710,051 - $783,771	-11,359 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $4.38 Million - $4.91 Million	-70,811 Reduced 86.18%	11,359 $767,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $567,334 - $635,563	-9,073 Reduced 9.94%	82,170 $5.34 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $2.2 Million - $2.87 Million	-36,321 Reduced 28.47%	91,243 $5.71 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $108,416 - $120,037	1,521 Added 1.21%	127,564 $9.85 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $1.33 Million - $1.55 Million	-20,423 Reduced 13.94%	126,043 $8.93 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $345,698 - $421,444	-4,746 Reduced 3.14%	146,466 $11 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $122,449 - $143,737	1,721 Added 1.15%	151,212 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2,091 - $2,478	29 Added 0.02%	149,491 $12.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	149,462	149,462 $10.6 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cap Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cap Wealth Advisors, LLC with notifications on news.

Account

Cap Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History